摘要
目的:研究Hes1对急性髓系白血病(AML)患者骨髓CD34+CD38-细胞的作用及其机制。方法:收集初治AML患者及正常供者骨髓样本后,通过密度梯度离心法获取单个核细胞,流式细胞术检测CD34+CD38-细胞比例及其细胞周期。通过免疫磁珠法分选CD34+CD38-细胞后,体外集落形成实验(CFC)检测其增殖能力,并通过Realtime PCR检测其Hes1的表达量。构建Hes1过表达逆转录病毒载体,感染正常供者骨髓CD34+细胞后,流式细胞术分析其细胞周期的改变,CFC检测其增殖的改变。结果:AML患者骨髓CD34+CD38-细胞比例明显低于正常对照,流式细胞术结果显示患者来源CD34+CD38-细胞大多数进入静止期,CFC结果显示患者CD34+CD38-细胞体外扩增能力下降。Realtime PCR结果发现患者CD34+CD38-细胞中Hes1表达上调。提高正常供者CD34+细胞中Hes1的表达后,细胞增殖减少,进入静止期。结论:在AML中CD34+CD38-细胞比例下降,进入静止期,与Hes1的表达上调有关。
Objective: To determine the effect of Hesl on bone marrow CD34+ cells in acute myeloid leukemia (AML). Meth- ods: Bone marrow mononuclear cells were isolated by using Ficoll. Then, the proportion and cell cycle of CD34+ cells were analyzed by using fluorescence-activated cell sorting (FACS). CD34~ cells were cultured in vitro for colony-forming cells (CFC). The expression of Hes 1 in CD34+ cells was evaluated by using real-time polymerase chain reaction. After upregulating the expression of Hes 1 in CD34+ cells, the cell cycle was analyzed through FACS, and the colony formation of CD34~Hes 1 + cells was analyzed by CFC. Results: The ra- tio of CD34~ cells in the bone marrow was lower in the AML group than in the control group. In addition, more CD34~ cells underwent quiescence in the AML group than in the control group. In vitro assay showed that the colony formation of CD34+ cells was lower in the AML group than in the control group. The expression of Hesl was higher in the CD34+ cells from the AML patients than that in the CD34+ ceils from normal donors. After Hesl transduction, more CD34+ ceils underwent quiescence and showed weak proliferation, Conclusion: The proportion of CD34+ cells in the bone marrow was lower in AML patients than in normal donors. A large proportion of CD34+ cells underwent quiescence, which was related to Hes 1, in AML patients.
出处
《中国肿瘤临床》
CAS
CSCD
北大核心
2014年第22期1422-1425,共4页
Chinese Journal of Clinical Oncology
基金
国家自然科学基金(编号:31301161)
天津市应用基础与前沿技术研究计划(编号:13JCYBJC22800)资助~~